Subscribe To
Marker Therapeutics Appoints Monic Stuart, M.D., as Chief Medical Officer
Accomplished healthcare executive brings extensive drug development and regulatory experience from global pharmaceutical companies to Marker Therapeutics HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the appointment of […] The post Marker Therapeutics Appoints...
Read More
Posted: May 8 2023, 11:30
Author Name: forextv
Views: 081812